Physician profile
Sameer Verma
NPI 1932334935
$8,359.39
in general payments reported to CMS, 2019-2025
42 companies · $1,240 in 2025
The $1,240 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,208 · 2020: $298 · 2021: $331 · 2022: $987 · 2023: $1,805 · 2024: $1,490 · 2025: $1,240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,534.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,054.19 | 2019-2020 | |
| Abbott Laboratories | $854.20 | 2019-2025 | Amplatzer Amulet, Aveir, Ensite |
| Novartis Pharmaceuticals Corporation | $696.73 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $466.17 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $433.49 | 2019-2025 | Farxiga, Lokelma |
| Biosense Webster, INC. | $425.33 | 2023 | Carto 3 |
| Medtronic, INC. | $381.01 | 2021-2025 | Micra |
| Merck Sharp & Dohme LLC | $377.82 | 2022-2025 | Verquvo, Belsomra, Capvaxive |
| Boston Scientific Corporation | $373.73 | 2019-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Abiomed | $368.50 | 2019-2025 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $344.91 | 2019-2025 | Jardiance |
| Amgen INC. | $236.59 | 2019-2025 | Repatha |
| Cvrx, INC. | $229.83 | 2023-2025 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $205.07 | 2019-2025 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $203.79 | 2019-2025 | Lifevest |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $188.73 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Biotronik INC. | $167.19 | 2019 | |
| Penumbra, INC. | $152.43 | 2021-2023 | Indigo System |
| Pfizer INC. | $149.57 | 2019-2025 | |
| Alnylam Pharmaceuticals INC. | $121.84 | 2024 | Amvuttra |
| Heartflow, INC. | $107.95 | 2023 | Ffrct |
| Kiniksa Pharmaceuticals, LTD. | $82.79 | 2022 | |
| Chiesi USA, INC. | $71.56 | 2019-2022 | |
| Philips North America LLC | $60.17 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $57.97 | 2024-2025 | |
| Kestra Medical Technology Services, INC. | $57.56 | 2023-2024 | Assure Wcd |
| Atricure, INC. | $56.83 | 2023 | |
| Agepha Pharma Fz LLC | $53.22 | 2024-2025 | Lodoco |
| Lexicon Pharmaceuticals, INC. | $47.58 | 2024 | |
| Impulse Dynamics (USA) INC. | $44.59 | 2022-2024 | Optimizer |
| Kiniksa Pharmaceuticals International, Plc | $41.43 | 2024 | Arcalyst |
| Shockwave Medical, INC | $40.18 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Glaxosmithkline, LLC. | $32.18 | 2023-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Zoll Circulation INC | $28.84 | 2023 | Catheter, Downstream Cartridge, Therox Ds2 Console |
| Edwards Lifesciences Corporation | $23.61 | 2023 | |
| Terumo Medical Corporation | $21.72 | 2025 | Tr Band |
| Lilly USA, LLC | $20.83 | 2025 | Zepbound, Mounjaro |
| Novo Nordisk INC | $20.45 | 2023 | Ozempic |
| Cardiovascular Systems INC. | $16.41 | 2019 | |
| Cordis US Corp. | $15.67 | 2024 | Mynx Control |
| Lucid Diagnostics INC. | $13.86 | 2022 | |
| Argon Medical Devices, INC. | $12.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameer Verma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.